Absence of Venous Thromboembolism Risk Following Quadrivalent Human Papillomavirus Vaccination, Vaccine Safety Datalink, 2008–2011

Project Title Absence of Venous Thromboembolism Risk Following Quadrivalent Human Papillomavirus Vaccination, Vaccine Safety Datalink, 2008–2011
Date
Saturday, January 2, 2016
Location
Description

To investigate concerns about a potential association between quadrivalent human papillomavirus vaccination (HPV4) and venous thromboembolism (VTE), a self-controlled case series study was conducted in adolescents and young adults 9–26 years of age in the Vaccine Safety Datalink.

Medical Product
quadrivalent human papillomavirus vaccination (HPV4)
Health Outcome
venous thromboembolism (VTE)
Corresponding Author

Allison L. Naleway, Center for Health Research, Kaiser Permanente Northwest, 3800 N. Interstate Ave., Portland, OR 97227; T: 1.503 335 6352; E: allison.naleway@kpchr.org
 

Authors

Allison L. Naleway PhD; Brad Cranea; Ning Smith; Matthew F. Daley MD; James Donahue; Julianne Gee Sharon K. Greene PhD, MPH; Theresa Harrington; Lisa A. Jackson MD, MPH; Nicola P. Klein MD, PhD; Hung Fu Tseng; Claudia Vellozzi MD; Eric S. Weintraub

 

Related Links